Journal of medical Internet researchOct 23, 2026

Widespread GLP-1 Antibodies and Their Impact on Body Weight Regulation

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗

Updated Oct 24, 2026

Abstract

GLP-1 medications are widely marketed, raising concerns about their impact on body image and well-being.

Widespread marketing of GLP-1 medications could influence public perceptions of body image.
Concerns have been expressed regarding the potential negative effects of these marketing practices on individual well-being.
Accessibility of GLP-1 medications may not translate to positive outcomes for all patients due to marketing implications.

Simplified

GLP-1 medications are incredibly accessible-while this may be a net positive for eligible patients, their widespread marketing may not be. In this News and Perspectives article, JMIR Correspondent Anna Zucker reports on concerns being raised about the potential impact of GLP-1 marketing practices on body image and well-being.

Widespread GLP-1 Antibodies and Their Impact on Body Weight Regulation

Abstract

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the glp-1 therapies brief